At the Forefront
Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse
Bibliographic Data
| ID | 10554102 |
|---|---|
| Authors | Claire Parker (0000-0002-7364-7046, School of Social Work, University of Texas at Arlington Claire Parker is a social work student, , 501 West Mitchell Street, Arlington, TX 76010, USA, corresponding author), Bethany M Wood (0000-0003-1367-0508, The University of Texas at Arlington) |
| Year | 2024 |
| Volume | 69 |
| Issue | 3 |
| Pages | 297-302 |
| Publication date | 2024-05-02 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Social Work (JOURNAL) |
| Journal identifiers | ISSN: 0037-8046 • E-ISSN: 1545-6846 |
| Publisher | Oxford University Press (OUP) (PUBLISHER) |
| DOI | 10.1093/sw/swae019 |
| PMID | 38697188 |
| OpenAlex | W4396599639 |
| Language | EN |
| Citations received | 1 |
| References cited | 31 |
This article underscores the critical role of social workers in harnessing the potential therapeutic benefits of psilocybin for treating major depressive disorder (MDD) and substance use disorder (SUD). Contemporary treatments for MDD often have side effects, and the success rate for SUD treatments remains low. The pervasiveness of MDD, combined with the challenges in treating SUD, highlights a need for innovative treatments. This article provides an overview of the resurgence of literature over the past two decades that illuminates the therapeutic promise of psilocybin for mental health treatment; clinical trials elucidate the efficacy of psilocybin-assisted therapy in mitigating MDD and demonstrate great promise in reducing SUD symptoms. The long-lasting posttreatment effect emphasizes its potential as a novel treatment modality. Furthermore, psilocybin's recognition as a "breakthrough therapy" by the U.S. Food and Drug Administration (FDA) and the accelerating pace of psychedelic reform bills indicate growing acceptance and interest in its therapeutic capacities. Psilocybin-assisted therapy emerges as a potent treatment option, showcasing remarkable effectiveness even after a single dose. Recommendations and pathways for social workers to be involved in psilocybin-assisted therapy investigation, advocacy, and implementation are provided
Cognition · Hallucinogen · Major depressive disorder · Psilocybin · Psychiatry · Psychotherapist · Substance abuse · Chemical synthesis and alkaloids · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies · Psychology
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Psilocybin with psychological support for treatment-resistant depression
Inclusion of people of color in psychedelic-assisted psychotherapy
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Drug Dependence, a Chronic Medical Illness
Long-term follow-up of psilocybin-facilitated smoking cessation
Psilocybin-assisted treatment for alcohol dependence
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2025 - 2025 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |